Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
GSK-4382276A by GSK for Seasonal Influenza: Likelihood of Approval
GSK-4382276A is under clinical development by GSK and currently in Phase II for Seasonal Influenza. According to GlobalData, Phase II...